Part,  Chapter, Paragraph

 1   II,     5.  4.  2|           diabetic subjects and a HbA1c tested in last 12 months~16~Percent
 2   II,     5.  4.  2|           diabetic subjects and a HbA1c tested, with HbA1c>7.5%~14~Percent
 3   II,     5.  4.  2|            Percent of diabetic subjects tested in the last 12 months with
 4   II,     5.  4.  2|            Percent of diabetic subjects tested in the last 12 months with
 5   II,     5.  4.  2|            Percent of diabetic subjects tested in the last 12 months with
 6   II,     5.  4.  2|            Percent of diabetic subjects tested in the last 12 months with
 7   II,     5.  4.  2|            Percent of diabetic subjects tested for microalbuminuria in
 8   II,     5.  4.  2|                diabetic subjects with a tested microalbuminuria in the
 9   II,     5.  4.  2|                diabetic subjects with a tested blood pressure measurement
10   II,     5.  4.  2|                diabetic subjects with a tested blood pressure in the last
11   II,     5.  4.  2|            Percent of diabetic subjects tested in the last 12 months, with
12   II,     5.  4.  2|            Percent of diabetic subjects tested serum creatinine in last
13   II,     5.  4.  2|          diabetic population with HbA1c tested and a value of HbA1c above
14   II,     5.  4.  2|                 their total cholesterol tested in the last 12 months.~Total
15   II,     5.  4.  2|                 their total cholesterol tested in last 12 months showing
16   II,     5.  4.  2|               had their LDL-cholesterol tested in the last 12 months.~LDL
17   II,     5.  4.  2|         population with LDL-cholesterol tested in the last 12 months and
18   II,     5.  4.  2|               had their LDL-cholesterol tested in the last 12 months.~HDL
19   II,     5.  4.  2|              with their HDL-cholesterol tested in the last 12 months and
20   II,     5.  4.  2|               their total triglycerides tested in the last 12 months.~Triglycerides
21   II,     5.  4.  2|                 their total cholesterol tested in last 12 months showing
22   II,     5.  4.  2|         Microalbuminuria should be also tested every year. The clinical
23   II,     5.  4.  2|               that had microalbuminuria tested (or proteinuria tested if
24   II,     5.  4.  2| microalbuminuria tested (or proteinuria tested if persistent proteinuria
25   II,     5.  4.  2|            microalbuminuria/proteinuria tested in last 12 months with a
26   II,     5.  4.  2|              had their serum creatinine tested during the last 12 months.~
27   II,     5.  4.  2|              population with creatinine tested in the last 12 months and
28   II,     5.  5.  3|         Programme will be developed and tested improving eating and lifestyle
29   II,     5.  5.  3|       association, and this needs to be tested.~It is important to mention
30   II,     5.  5.  3|               number of drugs are being tested some of which have shown
31   II,     5.  9.  4|                of sensitization to each tested allergen and in the prevalence
32   II,     5.  9.  4|               and the type of allergens tested vary widely. The geographical
33   II,     5.  9.  4|                 nine allergens were not tested); d1, Dermatophagoides pteronyssinus;
34   II,     5.  9.  4|    sensitization to nine allergens skin tested and standardized (age, gender)
35   II,     5.  9.  4|       sensitization each allergens skin tested~ ~National data, considered
36   II,     5.  9.  4|                prick test to any of the tested inhalant allergens and/or
37   II,     5. 11.  3|                 643 patients were patch tested and the highest sensitization
38   II,     5. 11.  3|              showed that only 8% of the tested piercing posts released
39   II,     5. 11.  3|              more~substances when patch tested but the proportion with
40   II,     7.  4.  1|            currently being produced and tested in pilot countries. Ultimately,
41   II,     8.  1.  4|              Lithuanian, is being pilot tested in Italy, Lithuania and
42   II,     8.  2.  1|              such as rubella, should be tested before getting pregnant.
43   II,     9.  2.  2|          developing commonly agreed and tested indicators, which produce
44   II,     9.  2.  5|              children have not yet been tested and authorised for use by
45   II,     9.  3.  1|          developing commonly agreed and tested indicators which produce
46   II,     9.  5.  4|          developing commonly agreed and tested indicators which produce
47  III,    10.  4.  2|             consignments that have been tested and rejected at EU external
48  III,    10.  4.  2|                that should be regularly tested. However, the number of
49  III,    10.  4.  2|                mainly because they were tested and rejected at EU external